← Open Payments lookup

WALLACE PURDY: Open Payments

NPI 1528166832 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$745 in 40 payments from 9 companies in 2025. Trend: 2023 $332 · 2024 $313 · 2025 $745

Food & beverage: $745
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$229
Novo Nordisk Inc5$110
Amgen Inc.6$98
Esperion Therapeutics, Inc.6$94
ABBVIE INC.3$68
Lilly USA, LLC3$51
PFIZER INC.2$51
Aroa Biosurgery Incorporated1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: FARXIGA, REPATHA, NEXLETOL, Ozempic, AIRSUPRA, MOUNJARO, ELIQUIS, UBRELVY.

Industry payments across AL — which companies pay providers there.